View in EDS

Reimagining GSK-3β Therapeutics in Alzheimer's Disease: From Inhibition to Activity Normalization and Targeted Degradation.

Saved in:
Bibliographic Details
Title: Reimagining GSK-3β Therapeutics in Alzheimer's Disease: From Inhibition to Activity Normalization and Targeted Degradation.
Authors: Manni E; Department of Clinical Laboratory Sciences, College of Applied Medical Sciences, Jouf University, Sakakah, Saudi Arabia., Al-Kuraishy HM; Department of Clinical Pharmacology and Medicine, College of Medicine, Al-Mustansiriyah University, Baghdad, Iraq., Eisawy R; Department of Biochemistry, Faculty of Veterinary Medicine, Alexandria University, Alexandria, Egypt., Abdelaziz AM; Department of Pharmacology and Toxicology, Faculty of Pharmacy, Sinai University-Arish Branch, Arish, 45511, Egypt. ahmed.abdelaziz@su.edu.eg., Batiha GE; Department of Pharmacology and Therapeutics, Faculty of Veterinary Medicine, Damanhur University, Damanhur, AlBeheira, 22511, Egypt. dr_gaber_batiha@vetmed.dmu.edu.eg.
Source: Journal of molecular neuroscience : MN [J Mol Neurosci] 2026 Apr 24; Vol. 76 (2). Date of Electronic Publication: 2026 Apr 24.
Publication Type: Journal Article; Review
Journal Info: Publisher: Humana Press Country of Publication: United States NLM ID: 9002991 Publication Model: Electronic Cited Medium: Internet ISSN: 1559-1166 (Electronic) Linking ISSN: 08958696 NLM ISO Abbreviation: J Mol Neurosci Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 42026238
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Reimagining GSK-3β Therapeutics in Alzheimer's Disease: From Inhibition to Activity Normalization and Targeted Degradation.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Manni+E%22">Manni E</searchLink>; Department of Clinical Laboratory Sciences, College of Applied Medical Sciences, Jouf University, Sakakah, Saudi Arabia.<br /><searchLink fieldCode="AU" term="%22Al-Kuraishy+HM%22">Al-Kuraishy HM</searchLink>; Department of Clinical Pharmacology and Medicine, College of Medicine, Al-Mustansiriyah University, Baghdad, Iraq.<br /><searchLink fieldCode="AU" term="%22Eisawy+R%22">Eisawy R</searchLink>; Department of Biochemistry, Faculty of Veterinary Medicine, Alexandria University, Alexandria, Egypt.<br /><searchLink fieldCode="AU" term="%22Abdelaziz+AM%22">Abdelaziz AM</searchLink>; Department of Pharmacology and Toxicology, Faculty of Pharmacy, Sinai University-Arish Branch, Arish, 45511, Egypt. ahmed.abdelaziz@su.edu.eg.<br /><searchLink fieldCode="AU" term="%22Batiha+GE%22">Batiha GE</searchLink>; Department of Pharmacology and Therapeutics, Faculty of Veterinary Medicine, Damanhur University, Damanhur, AlBeheira, 22511, Egypt. dr_gaber_batiha@vetmed.dmu.edu.eg.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%229002991%22">Journal of molecular neuroscience : MN</searchLink> [J Mol Neurosci] 2026 Apr 24; Vol. 76 (2). <i>Date of Electronic Publication: </i>2026 Apr 24.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Review
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Humana+Press%22">Humana Press </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>9002991 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1559-1166 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2208958696%22">08958696 </searchLink><i>NLM ISO Abbreviation: </i>J Mol Neurosci <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=42026238
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1007/s12031-026-02518-9
    Languages:
      – Code: eng
        Text: English
    Titles:
      – TitleFull: Reimagining GSK-3β Therapeutics in Alzheimer's Disease: From Inhibition to Activity Normalization and Targeted Degradation.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Manni E
      – PersonEntity:
          Name:
            NameFull: Al-Kuraishy HM
      – PersonEntity:
          Name:
            NameFull: Eisawy R
      – PersonEntity:
          Name:
            NameFull: Abdelaziz AM
      – PersonEntity:
          Name:
            NameFull: Batiha GE
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 24
              M: 04
              Text: 2026 Apr 24
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-electronic
              Value: 1559-1166
          Numbering:
            – Type: volume
              Value: 76
            – Type: issue
              Value: 2
          Titles:
            – TitleFull: Journal of molecular neuroscience : MN
              Type: main
ResultId 1